Genia’s mission is to make genetic information universally available. Our proprietary integrated circuits and NanoTag chemistry enable massively parallel single-molecule DNA sequencing. This versatile nanopore-based platform allows for single molecule, electrical, real-time analysis without the need for complicated optics, labels, amplification, or fluidics. By developing a true integrated circuit on standard semiconductor process technology, Genia’s sequencing platform enables the use of molecular diagnostics in everyday clinical care.
With the 2014 acquisition, Genia Technologies is part of Roche Sequencing.